One big problem with blood glucose meters has long been that you can’t convert the individual readings into patterns and trends so you can figure out what to do about them. Oh, sure, many meters have software that does this in one fashion or another but downloading the data into software is often difficult because the cable you need is unavailable or lost or left at home or the office. Even a bigger problem occurs when you take the meter to the doctor’s office and they don’t have a cable to use to download data to software for the doctor to analyze and make recommendations.
Diabetes technology section
Dexcom is making more friends. Already having partnerships with Animas and Omnipod, Dexcom has now signed a research and development agreement with Roche Diagnostics U.S. The plan is to integrate Dexcom's continuous glucose monitor into Roche's insulin pumps so you can see trends and blood glucose data in one handheld device.
Here's an excerpt from the announcement:
We've been talking about smart insulin pens for years. A smart pen that includes some of the helpful features found in today's smart pumps would help non-pump patients increase the success of their diabetes management greatly. Pendiq is a new digital insulin pen manufactured by Diamesco Co, that was announced at the European Association for the Study of Diabetes (EASD) meeting in Lisbon in September of 2011.
The SOLO MicroPump Insulin Delivery System is a patch pump originally made by Medingo and purchased by Roche in 2010. Solo received FDA approval in 2009 and is expected to be available in 2012. The system has 4 parts: a micropump composed of reusable electronics plus an insulin reservoir, a remote, and a cradle.
Successful diabetes management starts with accurate numbers. WaveSense is a new technology that personalizes each test to provide world class accuracy. It detects and corrects for common sources of error that make blood glucose measurements inaccurate. Some of the common errors are:
Blood Samples - Blood sample variations such as hematocrit level (the amount of red blood cells in the sample) or chemical interferences from food or beverages (such as vitamin C from orange juice).
The Debiotech JewelPump is a disposable patch pump with some similarities to the current Omnipod, as well as other patch pumps on the horizon. Debiotech, a Swiss company, teamed with ST Microelectronics to create this sleek pump system. Like most patch pumps, a separate controller is required to deliver bolus insulin doses. It use a microelectromechanical (MEMS) pumping system, that allows the pump to be kept small and light.
The Cellnovo Diabetes Management System includes an insulin patch pump, continuous activity monitor, and a cellular-enabled wireless touchscreen handset with integrated blood glucose meter. Their semi-patch pump (patch pump with a nearby infusion site) got a lot of attention in 2009 when it was first announced because of its small size and iPhone-like handset. They received CE approval in September of 2011 and expects to receive FDA approval in the US. They filed for 510(k) in November of 2016 and responded to a series of FDA questions in August of 2017. The FDA has requested further information, but approval is anticipated in 2018.